Project Grant HT94252510519
Award Date
8/15/25
Completion Date
8/14/27
Dollars Obligated
$818K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Antonio, TX 78240, USA
Similar Awards
The federal Project Grant award of $856,523.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research to transform healthcare for military service members and the public. The award, effective September 30, 2025 through September 29, 2028, will fund research by the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to investigate neurovascular and cognitive recovery from a...
This federal Project Grant award of $1,008,313.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support advanced biomedical research by The Regents of the University of California, San Francisco (UCSF). The award, effective September 1, 2024 through August 31, 2027, will fund UCSF's research focused on transforming healthcare for military service members and the broader public. The research aims to advance disease prevention,...
The Defense Health Agency awarded a $5,099,737 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to 149 Bio LLC, located in Miami, Florida. The grant supports the development of a novel myeloid-targeted therapeutic for treating glomerular diseases. The four-year project, which commenced on July 1, 2025 and is scheduled for completion on June 30, 2029, aims to advance research and transformative healthcare solutions for military service members and the...
This federal Project Grant award of $2,377,839.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports evidence-based prediction of cardiovascular risk in immune-mediated inflammatory disease. The award, granted to the Regents of the University of California, San Francisco on June 1, 2025, aims to advance biomedical research and transform healthcare for military service members and the broader public. The 4-year research...
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...
This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The grant funds The Regents of the University of California, San Francisco (UCSF) to conduct research across multiple medical disciplines, including cancer research, neuroscience, rare diseases,...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
This federal Project Grant award, valued at $358,264.00, was issued on February 1, 2025 by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The award is funding research by Cornell University to target inflammatory pathways in breast cancer brain metastases for the treatment of edema and radiation necrosis using anti-VEGF ultrasmall particle therapy. The research aims to transform healthcare for military service members and the broader...
The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $750,000 Project Grant to Stanford University to implement a spatial and single-cell multiplexed platform for the development of targeted therapies for vascularized composite allotransplantation. The funding is provided through the Military Medical Research and Development (CFDA 12.420) federal grant program, which supports advanced biomedical research to transform healthcare for military service members and the broader...
The federal Project Grant award, ID HT94252410597, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $300,000.00 award, effective September 1, 2024 through August 31, 2026, will support research conducted by Duke University to study the "complement-activating properties of anti-SM/RNP antibodies in SLE". The research aims to advance scientific understanding and potential medical solutions related to this area of...